From: Video-EEG-monitoring to guide antiseizure medication withdrawal
Variables |  | N = 55 | |
---|---|---|---|
 |  | SW N = 50 | FW N = 5 |
Male/Female | Â | 19/31 | 1/4 |
Age at inclusion, years [median (range)] |  | 38 (18–75) | 26(19–68) |
Duration of hospital stay, days[median (range)] |  | 7(3–9) | 7(5–7) |
Diagnosis | FE | 1 | 4 |
 | GGE | 1 | - |
 | PNES | 36 | - |
- | FE/PNES | - | 1 |
 | GGE/PNES | 1 | - |
 | ASS | 4 | - |
 | FTS | 3 | - |
 | UE | 2 | - |
 | Other | 2 | - |
Age at seizure onset, years [median (range)] |  | 30,5 (2–74) | 21(12–67) |
Febrile seizures yes/no/unknown | Â | 1/40/9 | 0/4/1 |
Cerebral trauma yes/no/unknown | Â | 10/38/3 | 1/3/1 |
History of CNS-Infection yes/no/unknown | Â | 4/44/2 | 1/4/0 |
Positive family history yes/no/unknown | Â | 9/36/5 | 0/4/1 |
Withdrawal group | Group 1 | 2 | - |
 | Group 2 | 42 | 2 |
 | Group 3 Group 4 | 6 - | 3 - |
Seizure free interval, months [median (range)] |  | 0 (0-240) | 5(0–60) |
Number of ASM taken before withdrawal, [median (range)] |  | 1 (1–13) | 2 (1–2) |
Duration of ASM treatment before withdrawal, months [median (range)] |  | 13,5 (1-348) | 48 (3–81) |